Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
OBJECTIVE: to evaluate the safety and efficacy of a brief intracoronary infusion of ADO
applied at the time of reperfusion to limit infarct size and LV remodelling in patients with
ACSST submitted to primary ACTP.
DESIGN: Multicentric, prospective, randomised, parallel, placebo-controlled double-blind
study.
PATIENTS: 200 patients older than 18 with ACSST and without prior myocardial infarction
receiving primary PTCA within 6 hours after symptom onset.
Phase:
Phase 3
Details
Lead Sponsor:
David Garcia-Dorado
Collaborators:
Hospital Clínico Universitario de Valladolid Hospital General Universitario Gregorio Marañon Hospital Universitario Virgen Macarena Instituto de Ciencias del Corazon